drugset / Trial / NCT01426100
CKD-828 Telmisartan Non-Responder Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of the present study is to evaluate the efficacy and safety of two dose combination of Telmisartan/S-Amlodipine (40/2.5mg and 40/5mg) compared with telmisartan monotherapy (80mg) in hypertensive patients inadequately controlled by telmisartan monotherapy.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-05
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-amlodipine | Unknown | 2.5 mg | — |
| Subject | S-amlodipine | Unknown | 5 mg | — |
| Comparator | Telmisartan | Other / unclassified | 40 mg | — |
| Comparator | Telmisartan | Other / unclassified | 80 mg | — |